OasisLMS

JOPHON Courses offer continuing education created from JOPHON, APHON’s acclaimed journal. These courses feature original, peer-reviewed research aimed at enhancing clinical nursing care for children and adolescents with cancer and blood disorders, and their families.

 This course on ifosfamide-induced neurotoxicity (IIN) is designed for healthcare professionals to enhance their understanding and management of this condition. Participants will explore the incidence, symptoms, and risk factors associated with IIN, including direct neuronal injury and inadequate hydration. The course will delve into the pathophysiology, differential diagnosis, evaluation, and typical management strategies for IIN. Additionally, it will highlight the critical role of nurses and advanced practice nurses in educating families about IIN and providing care for children who develop this condition. By the end of the course, participants will be equipped with the knowledge and skills to effectively manage IIN and improve patient outcomes.

• Describe the incidence, clinical manifestations, and risk factors associated with ifosfamide-induced neurotoxicity (IIN) in pediatric patients with solid tumors
• Summarize the pathophysiology of IIN and review the assessment and clinical management of pediatric patients who develop IIN
• Discuss the role of nurses in recognizing IIN, providing supportive care and educating patients, families, and clinical staff

APHON will provide 1 nursing continuing professional development (NCPD) contact hour(s) for the successful completion of this course. Successful completion of:

1. JOPHON Article Review
2. Post-Test
3. Evaluation

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points. You may claim 1 NCPD in one of the following ILNA categories: Care Continuum, Psychosocial Dimensions of Care, OR Care of the Pediatric Hem/Onc Patient

The Association for Pediatric Hematology Oncology Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This provider is also approved by the California Board of Registered Nursing, Provider Number 14513.

None of the planners for this activity have relevant financial relationship(s) to disclose with ineligible companies.

Questions or concerns? Contact education@aphon.org.